Question Bank › Geographic or market replication just started wo

Geographic or market replication just started working outside the home base

Calls Tested
500
Answered YES
34
Hit Rate
6.8%
rare by design

Charles River Laboratories International, Inc. (CRL) — this company's answers

NO on the Q2 2022 call 2022-08-03 C
The model's full reasoning — Q2 2022 call → NOWe need to determine if management describes a business proven in original market/setting that has recently begun producing real results in new territory, with early evidence that the proven model travels, while new territories remain small share. Look for such pattern. The transcript discusses various segments. Key: "CRADL" and "Explora" - Charles River Accelerator and Development Lab, and Explora BioLabs acquisition. CRADL provides turnkey research capacity to biopharma clients in key bio hubs. Explora added capacity on West Coast. They are expanding footprint, adding facilities in California and London, aiming for 25 vivarium facilities with 300k sq ft by end of 2022. This seems like a model of providing lab space. Is this a proven business in original market? The company's original business is research models and services. CRADL is a new initiative? Actually, CRADL is described as "Charles River Accelerator and Development Lab" which provides turnkey research capacity. It seems like a new model. But is it proven in home? The question asks: "a business already proven in the company's ORIGINAL market, territory, or setting has RECENTLY begun producing REAL RESULTS IN NEW TERRITORY" - meaning the company has an established business in its original market, and now that same offering is working in new territories. Here, CRADL/Explora is about providing lab space. Is that the company's original business? The company's original business is research models (animals) and services. CRADL is a new offering? Actually, the transcript says: "Insourcing Solutions growth was driven by the CRADL initiative or Charles River Accelerator and Development Lab, which provides turnkey research capacity to small and large biopharmaceutical clients in key bio hubs. Clients are increasingly adopting this flexible model to access laboratory space without having to invest in internal infrastructure. The acquisition of Explora BioLabs in April, came at an opportune time enabling us to provide clients with additional capacity and scientific capabilities principally on the West Coast. It also added a new growth engine for the RMS segment by allowing us to accommodate more of our biopharmaceutical clients' needs, particularly biotech clients who have limited or no internal infrastructure in which to conduct research.

← Back to the full CRL analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that a business already proven in the company's ORIGINAL market, territory, or setting has RECENTLY begun producing REAL RESULTS IN NEW TERRITORY — additional regions, countries, markets, or settings the company has recently entered — with management presenting the away-from-home results as early evidence that the proven model travels, while the new territories remain a small share of the company today? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent pattern with all three present: (1) A HOME-PROVEN BASE: the company has an established, working business in its original market or setting, treated by management as demonstrated rather than in question; (2) AWAY RESULTS NOW REAL AND RECENT: in the recent period, the new territories or markets are actually transacting — real customers, orders, revenue, openings, volumes, or usage happening there now, described with concrete substance and recency, not merely entered, announced, or staffed; and (3) EARLY AND EXPANDING: management conveys that the new-territory contribution is still a small part of the company, that the early results support pressing further, and that continued expansion is underway or committed — so the reported results reflect mostly the home business while the replication is just beginning to layer on top. The territory may be geographic or a genuinely distinct market or setting; what matters is the same proven offering now demonstrably working in a second place. Answer NO if the away expansion is only planned, announced, or pre-revenue. NO if new territories are already the bulk of the business. NO if the away results are one immaterial anecdote. NO if expansion is chiefly by acquisition just consolidated rather than the company's own model replicating. NO if the home business itself is failing and expansion is escape. NO if the pattern appears only in an analyst's question management does not affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ASO Academy Sports and Outdoors, Inc. Q1 2024 2024-06-11 C+
LINC Lincoln Educational Services Corporation Q1 2024 2024-05-06 B+
GRBK Green Brick Partners, Inc. Q3 2023 2023-11-01 B
FSBC Five Star Bancorp Q3 2023 2023-10-31 B
TGLS Tecnoglass Inc. Q2 2023 2023-08-08 A
PTLO Portillo's Inc. Q2 2023 2023-08-05 B
PFIE Profire Energy, Inc. Q1 2023 2023-05-13 B
M Macy's, Inc. Q4 2022 2023-03-02 D
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
HBB Hamilton Beach Brands Holding Company Q3 2022 2022-11-05 C
SYY Sysco Corporation Q1 2023 2022-11-01 C+
HLNE Hamilton Lane Incorporated Q1 2023 2022-08-02 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
SE Sea Limited Q1 2022 2022-05-17 F
ADSE ADS-TEC Energy PLC Q4 2021 2022-04-28 D
SOPH SOPHiA GENETICS SA Q4 2021 2022-03-15 C
RELY Remitly Global, Inc. Q4 2021 2022-03-02 B
VNDA Vanda Pharmaceuticals Inc. Q4 2021 2022-02-23 F
GTES Gates Industrial Corporation plc Q4 2021 2022-02-07 C+
MOMO Hello Group Inc. Q3 2021 2021-11-30 D
SXC SunCoke Energy, Inc. Q3 2021 2021-11-01 A
LOPE Grand Canyon Education, Inc. Q2 2021 2021-08-08 C
UFI Unifi, Inc. Q4 2021 2021-08-07 B
TENB Tenable Holdings, Inc. Q2 2021 2021-07-27 A
SATS EchoStar Corporation Q1 2018 2018-05-10 C+
INST Instructure's Q4 2017 2018-02-12 B+
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
IR Ingersoll-Rand Plc Q3 2017 2017-10-25 B
BIIB Biogen Inc. Q2 2017 2017-07-25 B
CNS Cohen & Steers, Inc. Q2 2017 2017-07-20 B
KHC The Kraft Heinz Company Q1 2017 2017-05-03 F
SHOO Steven Madden, Ltd. Q1 2017 2017-04-21 C
MDLZ Mondelez International, Inc. Q4 2016 2017-02-07 C
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

RELY · Q4 2021 → YESThe question is about whether management describes a business proven in the original market that has recently begun producing real results in new territories, with those new territories still a small ...YES The transcript shows management describing a home-proven base in the US (original market), with away-from-home results in new territories (outside the US) now real and recent—$120 million revenue in 2021, up from $58 million in 2020, across expanded corridors (over 2, 100 total, with 700+ new last year). These new territories remain a minority share at 26% of total revenue, described as early-stage investments supporting long-term growth via localization in unlaunched geographies, with the model replicating through the same playbook.
LOPE · Q2 2021 → YESThe question is about whether management describes a business proven in the original market that has recently begun producing real results in new territory, with all three elements: home-proven base, ...NO The transcript shows Orbis as an acquired business (29 months ago) that management is now expanding through new partnerships and sites in additional territories. This does not meet the criteria because the expansion is chiefly by acquisition and consolidation rather than the company's own model replicating independently in new territories. The away results are real and recent 4,210 enrollments up 13.2%, but the pattern does not fully align with the required home-proven base and early expanding replication of the original model.
TENB · Q2 2021 → YESThe question is about whether management describes a business proven in the original market that has recently begun producing real results in new territories, with those new territories still a small ...YES Management describes a home-proven base in traditional IT/VM, with recent real results in OT (six-figure cross-sell win at a large public utility, early deployments successful) and AD (early stages with successful traction), plus EMEA outperformance. These new settings remain small contributions today, with management framing 2024 investments as support for continued expansion of the proven model.

More from the question bank

Regular buyers moved from occasional to progNamed counterparty roster suddenly upgraded Management describes competitors unable to rThe economics improved before the volume arrThe company's product is being consumed fastConstraint-side candorAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.